Omega-3 (Fish Oil)
EPA and DHA can lower triglycerides and may support cardiovascular health — with effect sizes more modest than the marketing.
1-2 g/day combined EPA+DHA
Also known as: ubiquinone, ubiquinol, CoQ10
A real mitochondrial cofactor with limited clinical uses — heart failure and migraine prevention — and very little to offer healthy people.
One good RCT (Q-SYMBIO) supports benefit in chronic heart failure, and migraine prophylaxis has moderate support. The popular statin-myopathy use has failed in the better-controlled trials, and healthy-adult energy claims are unsupported.
CoQ10 has the most respectable-sounding mechanism of any supplement in the pharmacy: it is a genuine, non-negotiable component of mitochondrial energy production. Every cell needs it. Levels decline with age. It is easy to see why "take CoQ10 for energy" became such a durable sales pitch.
The problem is the leap from essential to supplementable. Your body synthesises CoQ10 and normally has enough, absorption of the oral form is poor, and there is little evidence that raising blood levels raises the concentration inside mitochondria where it would need to act. Deficiency states exist but are rare genetic disorders, not something a healthy adult drifts into.
Where it has produced results, the setting is disease. Q-SYMBIO randomised patients with moderate-to-severe chronic heart failure to 300 mg daily and reported reduced cardiovascular mortality and hospitalisation over two years — a single trial, not enormous, but a real mortality endpoint in a population whose failing hearts plausibly are energy-limited. Migraine prophylaxis is the other reasonable use, with several small positive trials.
The statin story is where expectation and evidence part company. The reasoning is sound: statins block the pathway that makes CoQ10, statin users get muscle aches, so replacing CoQ10 should help. Blood CoQ10 does indeed fall on statins. But when this was tested properly — including in trials that first confirmed patients' symptoms were genuinely statin-related using a blinded rechallenge — CoQ10 did not outperform placebo. Meta-analyses are split, and the better-designed trials tend to be the negative ones. It is cheap and harmless enough that trying it is reasonable; expecting much is not.
For healthy adults the honest answer is that nothing supports the energy claim. If you do take it, ubiquinol is somewhat better absorbed than ubiquinone and correspondingly pricier, and both need dietary fat. The one interaction that matters is warfarin: CoQ10 is structurally similar to vitamin K and can reduce its effect.
CoQ10 shuttles electrons between complexes I/II and III of the mitochondrial electron transport chain, making it essential to ATP production, and doubles as a fat-soluble antioxidant protecting membranes from lipid peroxidation. Statins inhibit HMG-CoA reductase, which sits upstream of both cholesterol and CoQ10 synthesis — the rationale for the statin-myopathy hypothesis.
Well tolerated up to 300 mg/day and often higher in trials. The clinically important issue is warfarin: CoQ10 resembles vitamin K structurally and may blunt anticoagulation, so INR needs monitoring if you start or stop it. Mild blood-pressure lowering can add to antihypertensive medication.
This guide is educational, not medical advice. Talk to a physician or pharmacist before starting any supplement, especially alongside prescription medication or a medical condition.
Evidence review last updated